NEW YORK (GenomeWeb News) - Shares in Illumina were up more than 29 percent, or $8.42, at $37.28 in mid-afternoon trading after the company reported strong second-quarter earnings.
As GenomeWeb News reported this morning, Illumina reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.
The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.
Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.
In Nature this week: ash dieback disease fungal genome, and more.
This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.
This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.